Detalhe da pesquisa
1.
Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer.
Cell Immunol
; 365: 104376, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984534
2.
Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin.
Cell Mol Biol Lett
; 26(1): 2, 2021 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435886
3.
A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China.
Med Sci Monit
; 27: e930097, 2021 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33550324
4.
Mean platelet volume predicts prognosis in patients with diffuse large B-cell lymphoma.
Hematol Oncol
; 36(1): 104-109, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28736928
5.
Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma.
Ann Hematol
; 96(2): 237-243, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27807649
6.
Identification of pneumococcal serotypes with individual recognition of vaccine types by a highly multiplexed real-time PCR-based MeltArray approach.
J Microbiol Immunol Infect
; 57(1): 107-117, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919170
7.
Low-dose radiotherapy synergizes with iRGD-antiCD3-modified T cells by facilitating T cell infiltration.
Radiother Oncol
; 194: 110213, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458258
8.
Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Clin Epigenetics
; 16(1): 48, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528641
9.
Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).
BMJ Open
; 14(2): e079442, 2024 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309748
10.
Prognostic significance of ß2-microglobulin decline index in multiple myeloma.
Front Oncol
; 14: 1322680, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562177
11.
Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma.
Front Pharmacol
; 15: 1377370, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38818376
12.
Newly developed 3D in vitro models to study tumor-immune interaction.
J Exp Clin Cancer Res
; 42(1): 81, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016422
13.
Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT).
Front Oncol
; 13: 1274487, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37869085
14.
Metagenomic next-generation sequencing for detecting lower respiratory tract infections in sputum and bronchoalveolar lavage fluid samples from children.
Front Cell Infect Microbiol
; 13: 1228631, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662001
15.
TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial.
Front Oncol
; 13: 1304767, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053659
16.
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumor.
Bioeng Transl Med
; 8(6): e10585, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023696
17.
Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma.
Front Immunol
; 14: 1146861, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37234150
18.
Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
BMJ Open
; 13(10): e076048, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802608
19.
Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma.
Front Pharmacol
; 14: 1203125, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608887
20.
Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma.
Front Cell Dev Biol
; 11: 1159355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37152283